Definitive Contract 75F40119C10083
Award Date
9/16/19
Potential Completion Date
9/15/20
Potential Value
$125K
Federal Agency
Food and Drug Administration
Awardee
Clinicahealth, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Arlington, VA 22201, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
12
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $100,000.00 firm fixed price contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Clinicahealth, Inc. The contract is for "SOCIAL LISTENING AND PULMONARY ARTERIAL HYPERTENSION" and was awarded on September 14, 2017 with a completion date of July 31, 2018. The work is to be performed in Arlington, Virginia. The contract has no set-aside designation. Clinicahealth, Inc. is a for-profit...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price definitive contract worth $595,345.32 to Mark Herring Associates, Inc., a for-profit organization and Subchapter S Corporation. The contract is for a two-phase project, with Phase One involving the collection, analysis, interpretation, and reporting of qualitative data from approximately 140 individuals who have used prescription opioids and at least one of four other substances. The work...
This is a Firm Fixed Price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (HHS/FDA) to Inflexxion, Inc., a for-profit organization. The contract, with a potential value of $754,500.62, is for a DATA ENHANCEMENT PROJECT under the FDA Prescription Drug Abuse Summary Reports Master IDIQ contract vehicle. The project aims to provide DATA RESOURCE FOR POST-MARKETING PRESCRIPTION AND OVER-THE-COUNTER DRUG ABUSE SURVEILLANCE DATA. The contract does...
This is a $88,140 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Medstar Health Research Institute Inc., a non-profit organization, to conduct a study on neural injuries and dysfunctions in patients. The contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. The contract stems from a solicitation posted on May 27, 2020 for the procurement of patients diagnosed with mild or moderate traumatic brain...
The Department of Health and Human Services Food and Drug Administration awarded a $219,885.00 purchase order contract to Healthpartners Institute, a non-profit organization, to conduct a study on the association between oral transmucosal pain reduction drugs and dental adverse events using integrated real-world data sources. The contract has a completion date of December 31, 2023 and is a labor hours-based contract. No set-aside designation was used for this award. Healthpartners Institute is a...
This is a $180,000 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and medical research databases and analytics tools. The contract is for data acquisition services related to active pharmaceutical ingredients (APIs), including information on API manufacturing facilities and activities. This single-award contract has a completion date of September 24, 2021....
This is a new task order awarded under an existing Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSF223201610004I) with the Department of Health and Human Services Food and Drug Administration (FDA). The task order, valued at $2,470,791.00, is for a Pharmacokinetic (PK) study of opioid drug products following oral ingestion of chewed products. The study falls under the FDA's In Vivo Study of Generic Drug Products in Human Subjects program. The contract is a Firm Fixed Price...
The Food and Drug Administration (FDA) awarded a $1,046,568.62 firm-fixed price delivery order to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation, to study the prevalence, experiences, knowledge, and perceptions of falsified and unapproved pharmaceuticals among individuals being assessed for or entering substance use disorder treatment. This delivery order is part of a larger $10 million indefinite delivery contract the FDA has with Integrated Behavioral Health to...
This is a Firm Fixed Price contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Research Triangle Institute (RTI) International, a non-profit research organization. The $526,321.00 contract was awarded on July 16, 2019 under the FDA's Mission Oriented Business Integrated Services (MOBIS) federal contract vehicle, and the work is scheduled for completion on February 3, 2024. The contract is for "Targeted Mechanism of Action Claims in...
This is a $1,440,515.00 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Department of Health and Human Services Food and Drug Administration to the non-profit Research Triangle Institute (RTI) International. The contract is for "HEALTH CARE PROVIDERS' UNDERSTANDING OF OPIOID ANALGESIC ABUSE DETERRENT FORMULATIONS (ADFS)", which falls under the Major Program Code of "QUICK TURNAROUND SOCIAL SCIENCE RESEARCH SERVICES". The contract has a...